NIH-funded research R01 grant

Investigating heart metabolism changes during heart enlargement

Official title: Hexosamine biosynthesis pathway metabolism during cardiac hypertrophy

Funded at Seattle Children's Hospital · NIH-10980556 · Data updated 2026-11-12

This study is looking at how certain heart diseases make the heart work too hard and grow bigger, and it aims to find out how this affects the heart's energy use, which could help discover new ways to keep hearts healthier and prevent heart failure.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionSeattle Children's Hospital
NIH-funded
Lab location1 site (Seattle, United States)
Project startDecember 20, 2022
Project endNovember 30, 2027
Funding year2025
Award (this year)$735,425
NIH project number5R01HL163103-03
Project IDNIH-10980556 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with conditions that cause pressure overload on the heart, such as aortic stenosis or hypertension.

Less likely to help

Patients with heart conditions unrelated to pressure overload or those with advanced heart failure may not benefit from this research.

What this research studies

This research focuses on how various heart diseases, such as aortic stenosis and coarctation, lead to pressure overload on the heart, causing it to enlarge (hypertrophy). The study aims to understand the metabolic changes that occur in the heart during this process, particularly how the heart shifts its energy sources from fatty acids to glucose. By exploring the mechanisms behind these changes, the research seeks to identify new therapeutic strategies that could help the heart adapt better and prevent heart failure. The research involves both animal models and human samples to uncover the underlying biochemical pathways.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that improve heart function and prevent heart failure in patients with pressure overload conditions.

How similar studies have gone: Previous research has shown promising results in understanding metabolic changes in the heart, but this specific approach to targeting the hexosamine biosynthesis pathway is relatively novel.

Where this research is happening

  • Seattle Children's Hospital
    Seattle, United States
    Active

Researchers

  • Principal investigator: Olson, Aaron K — Seattle Children's Hospital
  • Study coordinator: Olson, Aaron K

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.